Tripping into Treatment: Comparing Initial and Current Motivations for Psychedelic Use
Daniel J. Kruger, Jeff Albrecht, Jacob S. Aday, Julie Barron, Moss Herberholz, Kevin F. Boehnke
Journal of Psychoactive Drugs February 5, 2025 DOI: 10.1080/02791072.2025.2461999 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Qualitative Peer reviewed |
|---|---|
| Sample size | 1,221 |
| Population | Participants reporting naturalistic psychedelic use |
| Keywords | Tripping Current fluid Psychotherapist |
| Citations | 3 |
| Key findings | Motivations for psychedelic use change over time, shifting from initial recreation or exploration to later therapeutic or personal growth reasons. |
Abstract
Psychedelic drugs are currently being explored for their therapeutic potential for a variety of health conditions. The recent increased public interest in psychedelics necessitates empirical investigation into motivations for use among users as well as how motivations may change over time. We asked a large sample of participants reporting naturalistic psychedelic use (N = 1221) about their motivations for using psychedelics initially (i.e. their first time) as well as currently. We found that motivations for psychedelic use change substantially over time, with initial use typically for recreation or exploration, and later use more for therapeutic or personal growth reasons, including managing mental health conditions, growing spiritually, connecting with nature, improving creativity, and managing trauma. These results highlight the distinct and shifting motivations for engaging in psychedelic use. Although the study was limited by a retrospective design, it is the first to show that motivations for using psychedelics may change over time, with initial use focused on recreation and curiosity but subsequent use more motivated by self-improvement (e.g. enhancing relationships and health). Future prospective designs and qualitative interviews may aid in further elucidating the mechanisms underlying these shifts in motivations over time.
Citations in the library
Cited by 3
- A lexicon for psychedelic research and treatment Drug Science, Policy and Law September 1, 2025
- Contemplating versus having used psychedelics in bipolar disorder - What makes the difference? Journal of Affective Disorders February 1, 2026
- Field Notes From Inner Space: Global Psychedelic Survey Participants Report Health Benefits, Personal Growth, and Life Transformations Contemporary Drug Problems April 25, 2026
Cites 24
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
- The Varieties of Self-Transcendent Experience Review of General Psychology May 1, 2017
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder JAMA Psychiatry August 24, 2022
and 19 more in the library